Daytime symptoms of restless legs syndrome - clinical characteristics and rotigotine effectiveness

Sleep Medicine

Volumn 16, Issue 7, 2015, Pages 871-876

  Takahashi, Masayoshi ^a,b   Ikeda, Junji ^b   Tomida, Takayuki ^b   Hirata, Koichi ^c   Hattori, Nobutaka ^d   Inoue, Yuichi ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b OTSUKA PHARMACEUTICAL CO LTD   (Japan)

^c DOKKYO MEDICAL UNIVERSITY   (Japan)

^d JUNTENDO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Daytime; Dopamine agonist; Patch; Restless legs syndrome; Rotigotine

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; PLACEBO; ROTIGOTINE; TETRALIN DERIVATIVE; THIOPHENE DERIVATIVE;

ADULT; ARTICLE; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CIRCADIAN RHYTHM; CLINICAL FEATURE; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DEPRESSION; DISEASE DURATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; EPWORTH SLEEPINESS SCALE; FEMALE; HUMAN; INSOMNIA; INTERNATIONAL RESTLESS LEGS SYNDROME STUDY GROUP RATING SCALE; JAPANESE (PEOPLE); LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE ASSESSMENT; PARALLEL DESIGN; PITTSBURGH SLEEP QUALITY INDEX; POST HOC ANALYSIS; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTLESS LEGS SYNDROME; TREATMENT DURATION; TREATMENT OUTCOME; AGED; CUTANEOUS DRUG ADMINISTRATION; DOSE RESPONSE; DRUG ADMINISTRATION; MIDDLE AGED;

ADMINISTRATION, CUTANEOUS; ADULT; AGED; CIRCADIAN RHYTHM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; RESTLESS LEGS SYNDROME; TETRAHYDRONAPHTHALENES; THIOPHENES; TREATMENT OUTCOME;

EID: 84930572095     PISSN: 13899457     EISSN: 18785506     Source Type: Journal    
DOI: 10.1016/j.sleep.2015.03.006     Document Type: Article

References (29)

1. Hening W.A., Walters A.S., Wagner M., et al. Circadian rhythm of motor restlessness and sensory symptoms in the idiopathic restless legs syndrome. Sleep 1999, 22:901-912.
2. Trenkwalder C., Hening W.A., Walters A.S., Campbell S.S., Rahman K., Chokroverty S. Circadian rhythm of periodic limb movements and sensory symptoms of restless legs syndrome. Mov Disord 1999, 14:102-110.
3. Michaud M., Dumont M., Paquet J., Desautels A., Fantini M.L., Montplaisir J. Circadian variation of the effects of immobility on symptoms of restless legs syndrome. Sleep 2005, 28:843-846.
4. Walters A.S. Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group. Mov Disord 1995, 10:634-642.
5. Allen R.P., Walters A.S., Montplaisir J., et al. Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med 2005, 165:1286-1292.
6. Winkelman J.W., Finn L., Young T. Prevalence and correlates of restless legs syndrome symptoms in the Wisconsin Sleep Cohort. Sleep Med 2006, 7:545-552.
7. Hening W.A., Allen R.P., Chaudhuri K.R., et al. Clinical significance of RLS. Mov Disord 2007, 22(Suppl. 18):S395-400.
8. Tison F., Crochard A., Leger D., Bouee S., Lainey E., El Hasnaoui A. Epidemiology of restless legs syndrome in French adults: a nationwide survey: the INSTANT Study. Neurology 2005, 65:239-246.
9. Tzonova D., Larrosa O., Calvo E., et al. Breakthrough symptoms during the daytime in patients with restless legs syndrome (Willis-Ekbom disease). Sleep Med 2012, 13:151-155.
10. Garcia-Borreguero D., Ferini-Strambi L., Kohnen R., et al. European guidelines on management of restless legs syndrome: report of a joint task force by the European Federation of Neurological Societies, the European Neurological Society and the European Sleep Research Society. Eur J Neurol 2012, 19:1385-1396.
11. Aurora R.N., Kristo D.A., Bista S.R., et al. The treatment of restless legs syndrome and periodic limb movement disorder in adults - an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses: an American Academy of Sleep Medicine Clinical Practice Guideline. Sleep 2012, 35:1039-1062.
12. Garcia-Borreguero D., Stillman P., Benes H., et al. Algorithms for the diagnosis and treatment of restless legs syndrome in primary care. BMC Neurol 2011, 11:28.
13. Garcia-Borreguero D., Kohnen R., Silber M.H., et al. The long-term treatment of restless legs syndrome/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group. Sleep Med 2013, 14:675-684.
14. Inoue Y., Shimizu T., Hirata K., et al. Efficacy and safety of rotigotine in Japanese patients with restless legs syndrome: a phase 3, multicenter, randomized, placebo-controlled, double-blind, parallel-group study. Sleep Med 2013, 14:1085-1091.
15. Trenkwalder C., Benes H., Poewe W., et al. Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 2008, 7:595-604.
16. Hening W.A., Allen R.P., Ondo W.G., et al. Rotigotine improves restless legs syndrome: a 6-month randomized, double-blind, placebo-controlled trial in the United States. Mov Disord 2010, 25:1675-1683.
17. Oertel W., Trenkwalder C., Benes H., et al. Long-term safety and efficacy of rotigotine transdermal patch for moderate-to-severe idiopathic restless legs syndrome: a 5-year open-label extension study. Lancet Neurol 2011, 10:710-720.
18. Kohnen R., Oertel W.H., Stiasny-Kolster K., Benes H., Trenkwalder C. Severity rating of restless legs syndrome: validation of the RLS-6 Scales. Sleep 2004, 27:A304.
19. Allen R.P., Picchietti D., Hening W.A., et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003, 4:101-119.
20. Allen R.P. Improving RLS diagnosis and severity assessment: polysomnography, actigraphy and RLS-sleep log. Sleep Med 2007, 8(Suppl. 2):S13-18.
21. Inoue Y., Oka Y., Kagimura T., Kuroda K., Hirata K. Reliability, validity, and responsiveness of the Japanese version of International Restless Legs Syndrome Study Group rating scale for restless legs syndrome in a clinical trial setting. Psychiatry Clin Neurosci 2013, 67:412-419.
22. Buysse D.J., Reynolds C.F., Monk T.H., Berman S.R., Kupfer D.J. The pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res 1989, 28:193-213.
23. Doi Y., Minowa M., Uchiyama M., et al. Psychometric assessment of subjective sleep quality using the Japanese version of the Pittsburgh Sleep Quality Index (PSQI-J) in psychiatric disordered and control subjects. Psychiatry Res 2000, 97:165-172.
24. Johns M.W. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991, 14:540-545.
25. Takegami M., Suzukamo Y., Wakita T., et al. Development of a Japanese version of the Epworth Sleepiness Scale (JESS) based on item response theory. Sleep Med 2009, 10:556-565.
26. Radloff L.S. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977, 1:385-401.
27. Shima S., Shikano T., Kitamura T., Asai M. Reliability and validity of CES-D. Clin Psychiatry 1985, 27:717-723. in Japanese.
28. Garcia-Borreguero D., Allen R.P., Kohnen R., et al. Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute. Sleep Med 2007, 8:520-530.
29. Allen R.P., Ondo W.G., Ball E., et al. Restless legs syndrome (RLS) augmentation associated with dopamine agonist and levodopa usage in a community sample. Sleep Med 2011, 12:431-439.